wileyonlinelibrary.com/journal/cas
has been proved to exert wide-ranging pharmacological activities, with anti-tumor, anti-inflammatory, anti-oxidant, anti-microbial, anti-convulsant and anti-diabetic properties. [6] [7] [8] [9] Therefore, TQ has been regarded as a promising agent for numerous diseases. Previous studies have revealed that TQ may exhibit high anti-tumor efficiency against various cancers, such as breast cancer, gastric cancer, cervical cancer, colon cancer, central nervous system cancer, ovarian cancer, prostate cancer, bladder cancer and renal cell cancer. [10] [11] [12] [13] [14] [15] [16] [17] [18] It is well known that invasion and metastasis play vital roles in the progression of tumors. Recent research has shown that TQ can inhibit metastasis and EMT in prostate cancer via the transforming growth factor-beta/Smad2/3 signaling pathway. 19 Jun Li and his team also indicated that TQ inhibited the migration and invasion abilities in cervical cancer cells, which might be regulated via the expression of Twist1, Zeb1 and E-cadherin directly. 12 However, there are few studies that consider the effect of TQ on metastasis in renal cell cancer.
Autophagy is a self-digestion phenomenon, first identified by Christian de Duve in 1963, which is evolutionarily conserved from yeast to mammals. During the autophagy process, a doublemembrane vesicle, named autophagosome or autophagic vacuole, sequesters cytoplasmic proteins and organelles and then delivers them to lysosome, where they are degraded. 20 The role of autophagy in tumors constantly changes with the progression of tumors. In the early stages of tumor formation, autophagy suppresses cancer initiation through eliminating inflammation, genome instability and tissue damage. Alternatively, as a tumor grows, autophagy promotes tumor growth through providing substrates for metabolism. 21, 22 Emerging observations indicate that there is an intricate relationship between autophagy and metastasis in cancer. On the one hand, autophagy helps to support viability for the potentially metastatic cancer cells. On the other hand, autophagy tends to inhibit early metastasis and to reverse of epithelial-mesenchymal transition (EMT) in cancer cells. 23, 24 Hence, in the present study, we aim to explore the effect of TQ on metastasis in RCC and the role of autophagy in this process. We also elucidate the underlying molecular mechanisms.
| MATERIAL S AND ME THODS

| Cell culture
Human renal carcinoma cell lines ACHN and 786-O were purchased from ATCC (Manassas, VA, USA). The ACHN and 786-O cells were cultured in RPMI-1640 medium (Hyclone, UT, USA) supplemented with 10% FBS (Gibco, NY, USA), 1% antibiotic solution (penicillin 100 U/mL and streptomycin 100 g/mL) (Solarbio, Shanghai, China)
at 37°C in a humidified incubator with 5% CO 2. Invitrogen (Carlsbad, CA, USA). Protease inhibitor and phosphatase inhibitor were obtained from Roche (Basel, Switzerland).
| Reagents, antibodies and plasmid
The following primary antibodies were used in this study: anti-β- 
| Transwell migration and invasion assay
We used 24-well plates with chambers of 8-μm pore size (Millipore, 
| Wound healing assay
Renal cell cancer cells were seeded into 6-well plates with complete medium. We used 200-μL pipet tips to scratch wounds when the cells had grown to 90%. The plates were washed 3 times to remove the floated cells and then filled with serum-free medium containing different concentrations of TQ for 24 hours. The cells were observed at different time points and the wound closure was determined by inverted microscope.
| Tandem fluorescence microscopy
Renal cell cancer cells were plated into 6-well dishes with complete medium. When cells grew to 70%, the medium was discarded and replaced with serum-free medium. Then, the cells were transfected with tandem fluorescent mRFP-EGFP-tagged LC3 expressing plasmids using Lipofectamine 2000. After 6 hours, the medium contain- 
| Western blot
Renal cell cancer cells were lysed by RIPA buffer containing protease inhibitor or phosphatase inhibitor and PMSF for 10 minutes on ice. Then, the cell debris was collected and centrifuged at 12 400 g for 15 minutes. The supernatants were transferred into new tubes, and protein concentrations were detected by BCA Protein Assay Kit (Heart, Xi'an, China). The supernatants were mixed with 1/5 volume of 6X buffer and then boiled for 5 minutes. The whole proteins were subjected to 10%-15% SDS-PAGE and then transferred to PVDF membranes. The membranes were first sealed with 10% skim milk for 2 hours at room temperature and then incubated with primary antibodies overnight at 4°C. Subsequently, the membranes were washed with TBST 3 times and incubated with secondary antibodies for 1 hour. The membranes were visualized and measured using an ECL system (Bio-Rad, CA, USA).
| In vivo experiments
All animal experiments were performed in accordance with standard ethical guidelines and approved by the Ethics Committee of Xi'an Jiaotong University. Ten male nude mice were included in the study. 
| Immunohistochemical assay
Renal tumors were separated from xenograft mice and fixed with 10% formaldehyde for 24 hours. Then, they were embedded in paraffin and cut into 5-μm-thick sections. After that, the tissue sections were subjected to deparaffinization, rehydration, endogenous peroxidase blocking and antigen retrieval. Next, the sections were blocked with 1% BSA for 10 minutes. Subsequently, they were incubated with primary antibodies overnight and appropriate secondary antibodies for 1 hour. The sections were then visualized using a DBA kit following the manufacturer's instructions.
| Statistical analysis
All data were presented as mean ± SD of 3 independent experiments and analyzed using GraphPad Prism 5.2 software. In all cases, differences were considered statistically significant when P-value <.05.
| RE SULTS
| Thymoquinone suppresses migration, invasion and epithelial-mesenchymal transition in renal cell cancer cells
To choose proper concentrations of TQ in the present study, first we (Table S1 ). As shown in Figure 1A , 40 μmol/L TQ exhib- Figure 2D ). Collectively, these data indicate that TQ can induce autophagy in RCC cells.
| Inhibition of autophagy attenuates thymoquinone-induced anti-tumor effects in renal cell cancer cells
Accumulated evidence has suggested that there is an association between autophagy and metastasis. We hypothesized that autophagy induced by TQ may affect the migration and invasion in RCC cells.
To verify the hypothesis, 3-methyladenine (3-MA), an inhibitor of 
| AMPK/mTOR pathway is involved in anti-tumor effects of autophagy induction by thymoquinone in renal cell cancer cells
Numerous studies have indicated that autophagy can be mediated 
| Anti-tumor effects of thymoquinone on renal cell cancer cells in vivo
We further investigated the effects of TQ on RCC cell growth in a xenograft tumor model. As shown in Figure 5A , tumors in the group treated with TQ grew more slowly than those in the control group. 
| D ISCUSS I ON
Over the past 30 years, plant-derived drugs have gained increasing attention as they are relatively nontoxic and inexpensive when com- Autophagy is a catabolic cellular process in which the dysfunctional cytoplasmic constituents are removed to maintain metabolic balance. It occurs not only in normal cells but also in cancer cells. 30 It is widely accepted that autophagy plays a complex role in oncogenesis: it represses tumor growth in the early stages on the one hand but is required for progression to advanced or invasive tumors on the other hand. 24 During the past 5 years, autophagy induced by plantderived drugs has been widely studied in various tumors. In the present study, we first demonstrated that TQ-induced autophagy in a concentration-dependent manner in RCC cells, which was verified by inverted microscope, LC3 turnover assay and western blot.
There is an intricate connection between autophagy and metastasis. Autophagy is usually induced during the progression of various cancers to metastasis and it can promote tumor metastasis through numerous mechanisms, including promoting a stem cell phenotype, production of secreted factors and modulating the Rho signaling pathway. 24 In contrast, autophagic cells can act as a barrier against tumor progression through inhibiting the tumor transfer from primary sites to secondary sites. 31 A study has shown halofuginoneinduced autophagy suppresses breast cancer cell migration and invasion. 32 Meanwhile, in osteosarcoma cells, the activation of autophagy is associated with the suppression of EMT. 33 In the study, we used 3-MA to inhibit autophagy and observed the effects of TQ on migration, invasion and EMT in RCC cell lines 786-O and ACHN.
We, therefore, found that inhibition of autophagy could attenuate TQ-induced anti-metastasis effects in RCC cells.
The mTOR signaling pathway has been reported to be activated in nearly 100% of RCC, and inhibitors targeting the mTOR signaling seem to offer a promising therapy against RCC. In our supplementary experiments, we compared TQ with everolimus.
The results indicated that everolimus showed more anti-tumor effects as compared to TQ. However, the emergency of drug resistance has limited the application of mTOR inhibitors in clinical treatment and agents targeting multiple pathways have been widely studied. Because the mTOR signaling pathway plays a vital role in the process of autophagy, it is important to study the relationship between the mTOR pathway and autophagy. The mTOR includes 2 functionally and biochemically distinct complexes, mTORC1 and mTORC2. 34 Evidence has shown that mTORC1, but not mTORC2, plays a vital role in the regulation of autophagy.
The mTORC1 inhibition increases autophagy, while activation of mTORC1 represses this process. 34 AMPK is a cellular energy sensor that regulates homeostatic balance. It positively regulates autophagy by inhibiting the activity of mTORC1 through direct phosphorylation of its receptor, a regulatory-associated protein of mTOR. In conclusion, our study demonstrated that TQ exerted antimetastatic properties in RCC cell lines 786-O and ACHN. In addition, these characteristics, including inhibiting migration, invasion and EMT, were mainly dependent on TQ-induced autophagy.
Furthermore, we revealed that the mechanism by which TQ-induced autophagy inhibited the metastasis of RCC cells was regulated through the AMPK/mTOR pathway. These findings indicated the potential role of TQ-induced autophagy in cancer treatment and suggested that combining TQ with autophagy inhibitors might enhance its cancer suppression effects.
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